For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction
of respiratory disease due to equine herpesvirus type 1 (EHV-1) and type 4 (EVH-4) and by equine influenza type A2 virus. Benefits:
Incorporates the latest emerging North American EIV strain (Ohio/2003), as well as an established North American EIV strain
(Kentucky/2/95). Also incorporates a relevant Eurasian EIV strain (Newmarket/2/93). Unique EHV-1 equine respiratory origin isolate.
Minimal vaccine site reactions. Three dose regiment conforms to AAEP recommendations. Safe, all killed vaccine.
of respiratory disease due to equine herpesvirus type 1 (EHV-1) and type 4 (EVH-4) and by equine influenza type A2 virus. Benefits:
Incorporates the latest emerging North American EIV strain (Ohio/2003), as well as an established North American EIV strain
(Kentucky/2/95). Also incorporates a relevant Eurasian EIV strain (Newmarket/2/93). Unique EHV-1 equine respiratory origin isolate.
Minimal vaccine site reactions. Three dose regiment conforms to AAEP recommendations. Safe, all killed vaccine.
- (Loading SDS PDF) SDS Sheet